1,844
Views
3
CrossRef citations to date
0
Altmetric
H. K. Dewangan et al.

Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model

, &
Pages 2033-2042 | Received 12 Jul 2017, Accepted 18 Nov 2017, Published online: 27 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jiayu Zhong, Yu Xia, Liang Hua, Xiaomin Liu, Misi Xiao, Tiantian Xu, Bing Zhu & Hong Cao. (2019) Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3485-3491.
Read now
Mohsen Mehrabi, Naser Mohammadpour Dounighi, Seyed Mahdi Rezayat Sorkhabadi, Delaram Doroud, Amir Amani, Mehdi Khoobi, Soheila Ajdary & Younes Pilehvar-Soltanahmadi. (2018) Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 230-240.
Read now

Articles from other publishers (1)

Hitesh Kumar Dewangan. (2021) The Emerging Role of Nanosuspensions for Drug Delivery and Stability. Current Nanomedicine 11:4, pages 213-223.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.